Skip to main content

Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits.


Comment on
United States Preventive Services Task Force screening mammography recommendations: science ignored. [AJR Am J Roentgenol. 2011]

To read more, see the following article on the PubMed website: PMID: 21940562